Join ISPOR  | Sign up for mailing List  | Follow Us: LinkedIn Twitter Facebook
 

Economic burden of diabetes to the health system

Cuernavaca Mor. México–The costs of diabetes has  a high impact health system for patients, health system may enter into a financial collapse and patients may incur in upper pocket expenses and depletion attributable to diabetes.

The objective of the study, “Costos de la Diabetes en América Latina: Evidencias del Caso Mexicano,” published in Value in Health Special Issue: Pharmacoeconomics and Outcomes Research in Latin America (Volume 14, Supplement 1) of Value in Health, was to identify costs and economic burden of diabetes and its implications for the health system, institutions, the family, patients, and society as a whole. The study was authored by Armando Arredondo, PhD, and Esteban De Icaza, PhD, Investigadores del Instituto Nacional de Salud Pública, Cuernavaca Mor., México.

Economic burden of diabetes in Mexico is more of the pocket implications of families and patients. Of every 100 dollars in diabetes to spend, an average of 49-51 US dollars comes out of the pocket of users and their families.

Care costs are determined from the annual operating costs of average in the main event of the health system institutions in Mexico and the results were validated by group of experts on the management of diabetes. 

Armando Arredondo is currently the professor-researcher of the National Institute of Public Health, doctor of science in health systems with postdoctoral in economics and health policy.

Value in Health (ISSN 1098-3015), the official journal of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR),  publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions.  The journal is published bi-monthly and has a regular readership of over 6,000 clinicians, decision makers, and researchers worldwide.

ISPOR is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

For more information: www.ispor.org

Media Releases Index
 

Contact ISPOR @ info@ispor.org  |  View Legal Disclaimer
©2013 International Society for Pharmacoeconomics and Outcomes Research. All rights reserved under International and Pan-American Copyright Conventions. 
Website design by Eagle Systems USA, Inc.